Primary |
Pulmonary Arterial Hypertension |
37.5% |
Pulmonary Hypertension |
37.5% |
Crest Syndrome |
6.3% |
Drug Use For Unknown Indication |
6.3% |
Oxygen Saturation Decreased |
6.3% |
Portopulmonary Hypertension |
6.3% |
|
Rectal Haemorrhage |
12.5% |
Thyroxine Increased |
12.5% |
Vomiting |
12.5% |
Atrial Fibrillation |
6.3% |
Fall |
6.3% |
Helicobacter Infection |
6.3% |
Hypokalaemia |
6.3% |
Pulmonary Oedema |
6.3% |
Throat Tightness |
6.3% |
Transient Ischaemic Attack |
6.3% |
Treatment Failure |
6.3% |
Vulvovaginal Mycotic Infection |
6.3% |
Weight Decreased |
6.3% |
|
Secondary |
Pulmonary Arterial Hypertension |
35.6% |
Drug Use For Unknown Indication |
20.0% |
Pulmonary Hypertension |
16.3% |
Nonketotic Hyperglycinaemia |
14.8% |
Product Used For Unknown Indication |
5.9% |
Anticoagulant Therapy |
1.5% |
Pain |
1.5% |
Drug Abuse |
0.7% |
Jugular Vein Thrombosis |
0.7% |
Nausea |
0.7% |
Prophylaxis |
0.7% |
Prophylaxis Against Diarrhoea |
0.7% |
Prophylaxis Of Nausea And Vomiting |
0.7% |
|
Pulmonary Oedema |
14.0% |
Thrombocytopenia |
9.3% |
Dyspnoea |
7.0% |
Rash |
7.0% |
Weight Decreased |
7.0% |
Device Related Infection |
4.7% |
Headache |
4.7% |
Oedema |
4.7% |
Right Ventricular Failure |
4.7% |
Sepsis |
4.7% |
Stress |
4.7% |
Throat Tightness |
4.7% |
Unevaluable Event |
4.7% |
Ventricular Hypertrophy |
4.7% |
Left Ventricular Failure |
2.3% |
Multi-organ Failure |
2.3% |
Palpitations |
2.3% |
Platelet Count Decreased |
2.3% |
Premature Baby |
2.3% |
Pulmonary Arterial Pressure Increased |
2.3% |
|
Concomitant |
Pulmonary Arterial Hypertension |
23.2% |
Pulmonary Hypertension |
22.7% |
Product Used For Unknown Indication |
15.1% |
Dermatitis Atopic |
5.5% |
Right Ventricular Failure |
3.9% |
Atrial Fibrillation |
3.7% |
Cardiac Failure |
2.8% |
Rash |
2.8% |
Analgesic Therapy |
2.4% |
Cardiac Disorder |
2.2% |
Anaemia |
1.8% |
Drug Use For Unknown Indication |
1.8% |
Hypovolaemia |
1.8% |
Pneumonia |
1.8% |
Diabetes Mellitus |
1.7% |
Non-small Cell Lung Cancer Stage Iiia |
1.7% |
Anticoagulant Therapy |
1.3% |
Cor Pulmonale Chronic |
1.3% |
Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
Sedation |
1.1% |
|
Platelet Count Decreased |
16.1% |
Pulmonary Arterial Hypertension |
7.5% |
Right Ventricular Failure |
7.5% |
Pulmonary Hypertension |
6.5% |
Swelling |
6.5% |
Syncope |
6.5% |
Thrombocytopenia |
6.5% |
Vomiting |
6.5% |
Infection |
4.3% |
Pyrexia |
4.3% |
Cardiac Failure |
3.2% |
Device Related Infection |
3.2% |
General Physical Health Deterioration |
3.2% |
Myocardial Infarction |
3.2% |
Pulmonary Oedema |
3.2% |
Renal Failure |
3.2% |
Amnesia |
2.2% |
Chest Pain |
2.2% |
Condition Aggravated |
2.2% |
Death |
2.2% |
|